Corebridge Financial Inc. Decreases Holdings in Doximity, Inc. (NASDAQ:DOCS)

Corebridge Financial Inc. decreased its stake in Doximity, Inc. (NASDAQ:DOCS) by 2.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 145,058 shares of the company’s stock after selling 3,046 shares during the quarter. Corebridge Financial Inc. owned approximately 0.08% of Doximity worth $7,745,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also modified their holdings of the stock. Global Retirement Partners LLC lifted its stake in Doximity by 468.1% in the 4th quarter. Global Retirement Partners LLC now owns 534 shares of the company’s stock valued at $29,000 after buying an additional 440 shares in the last quarter. UMB Bank n.a. lifted its position in shares of Doximity by 69.1% in the fourth quarter. UMB Bank n.a. now owns 575 shares of the company’s stock valued at $31,000 after acquiring an additional 235 shares in the last quarter. Larson Financial Group LLC lifted its position in shares of Doximity by 49.4% in the fourth quarter. Larson Financial Group LLC now owns 756 shares of the company’s stock valued at $40,000 after acquiring an additional 250 shares in the last quarter. Optimum Investment Advisors acquired a new stake in shares of Doximity in the fourth quarter worth approximately $43,000. Finally, Morse Asset Management Inc purchased a new stake in shares of Doximity during the third quarter worth approximately $46,000. Hedge funds and other institutional investors own 87.19% of the company’s stock.

Insider Activity at Doximity

In other news, Director Timothy S. Cabral sold 20,000 shares of Doximity stock in a transaction on Monday, February 3rd. The stock was sold at an average price of $57.62, for a total value of $1,152,400.00. Following the completion of the sale, the director now directly owns 6,360 shares of the company’s stock, valued at approximately $366,463.20. The trade was a 75.87 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. 37.40% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on the company. Bank of America raised their price objective on Doximity from $54.00 to $57.00 and gave the company a “neutral” rating in a report on Monday, January 6th. Canaccord Genuity Group raised their price target on shares of Doximity from $60.00 to $71.00 and gave the stock a “hold” rating in a research note on Friday, February 7th. KeyCorp dropped their price objective on shares of Doximity from $70.00 to $65.00 and set an “overweight” rating for the company in a research note on Wednesday, January 8th. Mizuho increased their price objective on shares of Doximity from $55.00 to $65.00 and gave the company a “neutral” rating in a report on Monday, February 10th. Finally, Needham & Company LLC boosted their target price on Doximity from $65.00 to $82.00 and gave the stock a “buy” rating in a report on Friday, February 7th. Eleven investment analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $64.22.

Doximity Stock Performance

Doximity stock opened at $60.59 on Friday. The company’s 50 day simple moving average is $65.39 and its 200-day simple moving average is $54.15. Doximity, Inc. has a 1 year low of $22.96 and a 1 year high of $85.21. The company has a market capitalization of $11.31 billion, a price-to-earnings ratio of 60.59, a price-to-earnings-growth ratio of 4.10 and a beta of 1.34.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.